Steven Cohen Point72 Asset Management
Steven Cohen is the founder of Point72 Asset Management and previously built SAC Capital into one of the industry’s most profitable trading firms. Point72 operates a multi-manager platform combining fundamental long/short equity with systematic and other strategies. Cohen is also a major figure in sports ownership and philanthropy, while remaining one of the most closely followed names in hedge fund trading culture.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Neurocrine Biosciences
NBIX
|
+$260M |
| 2 |
Boeing
BA
|
+$233M |
| 3 |
Arista Networks
ANET
|
+$207M |
| 4 |
Qiagen
QGEN
|
+$193M |
| 5 |
Kenvue
KVUE
|
+$191M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Adobe
ADBE
|
+$365M |
| 2 |
AutoZone
AZO
|
+$239M |
| 3 |
Dominion Energy
D
|
+$186M |
| 4 |
Palo Alto Networks
PANW
|
+$185M |
| 5 |
Take-Two Interactive
TTWO
|
+$180M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 17.23% |
| 2 | Healthcare | 16.71% |
| 3 | Consumer Discretionary | 10.49% |
| 4 | Industrials | 8.78% |
| 5 | Energy | 6.22% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
401
Core & Main
CNM
$8.4B
| $20.1M | 0.06% |
+697,887
| New | +$21.5M |
|
402
Wynn Resorts
WYNN
$10.3B
| $20.1M | 0.06% |
217,390
-902,060
| -81% | -$90.5M |
|
|
AGEN
403
Agenus
AGEN
$364M
| $19.9M | 0.06% |
880,791
-58
| -0% | -$1.64K |
|
404
Royalty Pharma
RPRX
$27.3B
| $19.8M | 0.06% |
728,200
+198,000
| +37% | +$5.88M |
|
405
Liberty Live Group Series A
LLYVA
$9.36B
| $19.7M | 0.06% |
+617,337
| New | +$20.3M |
|
406
Johnson & Johnson
JNJ
$651B
| $19.7M | 0.06% |
+126,420
| New | +$20.9M |
|
407
PUT
State Street SPDR S&P Regional Banking ETF
KRE
$4.07B
| $19.6M | 0.06% |
470,000
+395,000
| +527% | +$17.6M |
|
|
CTLT
408
DELISTED
CATALENT, INC.
CTLT
| $19.6M | 0.06% |
+430,217
| New | +$20.1M |
|
409
BioCryst Pharmaceuticals
BCRX
$2.44B
| $19.5M | 0.06% |
2,758,813
-1,245,887
| -31% | -$8.95M |
|
410
Olin
OLN
$2.1B
| $19.4M | 0.06% |
387,811
+346,311
| +834% | +$18.7M |
|
411
Monster Beverage
MNST
$93.6B
| $19.3M | 0.06% |
+728,768
| New | +$20.7M |
|
412
Weatherford International
WFRD
$6.49B
| $19.3M | 0.06% |
+213,540
| New | +$18M |
|
|
DQ
413
Daqo New Energy
DQ
$919M
| $19.1M | 0.06% |
631,776
-68,244
| -10% | -$2.43M |
|
414
SPDR Gold Trust
GLD
$154B
| $19.1M | 0.06% |
111,250
| – | – |
|
|
FITB
415
Fifth Third Bancorp
FITB
$49.7B
| $19M | 0.06% |
748,931
-258,076
| -26% | -$6.96M |
|
416
Citizens Financial Group
CFG
$29.4B
| $19M | 0.06% |
707,187
-160,673
| -19% | -$4.59M |
|
417
CALL
Southwest Airlines
LUV
$19.8B
| $18.9M | 0.06% |
+698,400
| New | +$22.8M |
|
418
CrowdStrike
CRWD
$195B
| $18.8M | 0.05% |
+450,036
| New | +$17.5M |
|
419
Endava
DAVA
$169M
| $18.8M | 0.05% |
+327,900
| New | +$17.1M |
|
420
Baytex Energy
BTE
$3.36B
| $18.7M | 0.05% |
4,232,794
+3,037,000
| +254% | +$11.9M |
|
|
421
CALL
Kenvue
KVUE
$36.6B
| $18.6M | 0.05% |
+925,000
| New | +$21.4M |
|
422
On Holding
ONON
$10B
| $18.6M | 0.05% |
667,522
-128,731
| -16% | -$4.07M |
|
423
Protagonist Therapeutics
PTGX
$9.99B
| $18.5M | 0.05% |
+1,108,140
| New | +$21.5M |
|
424
Novartis
NVS
$302B
| $18.5M | 0.05% |
181,247
-725,039
| -80% | -$73.6M |
|
425
PUT
Netflix
NFLX
$331B
| $18.4M | 0.05% |
+488,000
| New | +$20.7M |
|
Similar funds
Steven Cohen's Q3 2023 Portfolio in Review
As of Q3 2023, Steven Cohen held 3,015 positions worth $34.3B, up 1.9% from $33.6B the previous quarter. Its ten largest holdings account for 14% of the portfolio.
Steven Cohen deployed $1.94B of net new capital in Q3 2023, opening 907 new positions and adding to 756 existing holdings. Its largest new stake was Hologic: 1,902,507 shares worth $132M.
By sector, the portfolio is most concentrated in Technology at 17% of assets, up from 17% a quarter earlier, followed by Healthcare and Consumer Discretionary.
On the sell side, the largest reduction was Adobe, an estimated $365M trimmed.
- Steven Cohen's largest Q3 2023 buy was Hologic: 1,902,507 shares worth $132M.
- Steven Cohen added most to Neurocrine Biosciences in Q3 2023, an estimated $260M increase.
- Steven Cohen's biggest Q3 2023 reduction was Adobe, cutting an estimated $365M.
- Steven Cohen fully exited Dominion Energy in Q3 2023, selling an estimated $186M.
- Steven Cohen's ten largest holdings make up 14% of its $34.3B portfolio in Q3 2023.
- Steven Cohen opened 907 new positions and closed 606 in Q3 2023.
- Steven Cohen's portfolio value rose 1.9% quarter-over-quarter to $34.3B.
Based on Point72 Asset Management's 13F filing for Q3 2023, filed 14 Nov 2023.